Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
2.080
+0.030 (1.46%)
At close: Feb 27, 2026, 4:00 PM EST
2.100
+0.020 (0.96%)
After-hours: Feb 27, 2026, 7:55 PM EST
Biomerica Employees
As of May 31, 2025, Biomerica had 54 total employees, including 53 full-time and 1 part-time employees. The number of employees decreased by 10 or -15.63% compared to the previous year.
Employees
54
Change (1Y)
-10
Growth (1Y)
-15.63%
Revenue / Employee
$82,537
Profits / Employee
-$74,537
Market Cap
6.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Lifeward | 80 |
| Beyond Air | 61 |
| Intelligent Bio Solutions | 55 |
| enVVeno Medical | 37 |
| Movano | 32 |
| Tenon Medical | 27 |
| HeartSciences | 15 |
| Autonomix Medical | 11 |
BMRA News
- 2 days ago - Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy - GlobeNewsWire
- 10 days ago - Vietnam Approves Biomerica's EZ Detect™ for Nationwide Distribution - GlobeNewsWire
- 6 weeks ago - Biomerica Reports Second Quarter Fiscal 2026 Financial Results - GlobeNewsWire
- 2 months ago - Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test - GlobeNewsWire
- 2 months ago - Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio - GlobeNewsWire
- 3 months ago - Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS - GlobeNewsWire
- 4 months ago - Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand - GlobeNewsWire
- 4 months ago - Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S. - GlobeNewsWire